Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 1622236Generated: October 30, 2026

1,3,2-Dioxaborolane, 2-[2-fluoro-4-[(methylsulfonyl)methyl]phenyl]-4,4,5,5-tetramethyl- → 4-[5-(2-Fluoro-4-methanesulfonylmethyl-phenyl)-2,3-dihydro-furo[2,3-c]pyridin-2-yl]-piperidine-1-carboxylic acid tert-butyl ester

https://huagongshe.com/reaction/1622236

Reaction equation

Participants

RoleNameHCIDCharge
Reactant1,3,2-Dioxaborolane, 2-[2-fluoro-4-[(methylsulfonyl)methyl]phenyl]-4,4,5,5-tetramethyl-HCID 67973780—
Reactant4-(5-Chloro-2,3-dihydrofuro[2,3-c]pyridin-2-yl)piperidine-1-carboxylic acid tert-butyl esterHCID 86674895—
Product4-[5-(2-Fluoro-4-methanesulfonylmethyl-phenyl)-2,3-dihydro-furo[2,3-c]pyridin-2-yl]-piperidine-1-carboxylic acid tert-butyl esterHCID 67990256—

Reaction Steps

The title compound is prepared from 4-(5-chloro-2,3-dihydro-furo[2,3-c]pyridin-2-yl)-piperidine-1-carboxylic acid tert-butyl ester and 2-(2-fluoro-4-methanesulfonylmethyl-phenyl)-4,4,5,5-tetramethyl-[1,3,2]dioxaborolane following a procedure analogous to that described for Intermediate 7. LC (method 6): tR=1.61 min; Mass spectrum (ESI+): m/z=491 [M+H]+.

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS08778926B2
Source datasetuspto-grants-2014_07
ORD IDord-063133262c1d465ebff6848bfccb2c58
Source noteuspto-grants-2014_07